首页> 外文期刊>Current pharmaceutical design >Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?
【24h】

Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?

机译:电辅助核酸在体内递送至组织:我们站在哪里?

获取原文
获取原文并翻译 | 示例
           

摘要

Electropulsation (electroporation) is a physical method for delivery of various molecules into the cells in vitro and in vivo. It is an expanding field due to its applicability in cancer therapy, where combined application of electric pulses and chemotherapeutic drugs is used for treatment of cutaneous and subcutaneous nodules of different malignancies. Another application of electropulsation in vivo is electrogene therapy, where after injection of naked plasmid DNA and delivery of electric pulses directly to the tissue the expression of gene of interest can be obtained. However, the transfection efficiency of this methodology in vivo is still lower than with viral vectors. Nevertheless, due to the lack of immunogenicity of the method, easiness of the preparation of large quantities of endotoxin free plasmid DNA, control and reproducibility of the method and the development of electropulsators approved for the clinical use, electrically-assisted nucleic-acid delivery holds a great potential for the clinical application. This aim of this minireview is to critically discuss the main limitations and obstacles associated with electrogene therapy and the failures and problems as well as the successes. Topics on electric field distribution in the tissue, electrode geometries, construction of plasmid, modulation of extracellular space, tissue damage, pro-inflammatory and immune response as well as blood flow modification associated with application of electric pulses and injection of naked DNA are presented with possible directions how to overcome these limitations. Furthermore, for successful electrogene therapy in clinical setting it is of utmost importance to elucidate the mechanisms of DNA transfer into the cells of tissues in vivo. This will enable appropriate selection of electric pulse parameters and plasmid DNA constructs for each particular intended use. In the long run, this review should encourage other scientists to consider electrically assisted gene delivery for gene therapy as it matures.
机译:电脉冲(电穿孔)是一种用于在体外和体内将各种分子递送到细胞中的物理方法。由于其在癌症治疗中的适用性,它是一个不断扩大的领域,其中电脉冲和化学治疗药物的联合应用被用于治疗不同恶性肿瘤的皮肤和皮下结节。体内电脉冲的另一种应用是电基因疗法,其中在裸质粒DNA注射并将电脉冲直接递送至组织后,可以获得目的基因的表达。但是,该方法在体内的转染效率仍低于病毒载体。然而,由于该方法缺乏免疫原性,易于制备大量无内毒素的质粒DNA,该方法的控制和可重复性以及批准用于临床的电脉冲发生器的开发,电辅助核酸输送仍然有效具有很大的临床应用潜力。这篇小型综述的目的是批判性地讨论与电基因疗法相关的主要局限性和障碍,以及失败与问题以及成功。提出了有关组织中电场分布,电极几何形状,质粒构建,细胞外空间调节,组织损伤,促炎和免疫反应以及与电脉冲施加和裸DNA注射相关的血流调节的主题。可能的方向如何克服这些限制。此外,对于临床上成功的电基因治疗,阐明体内DNA转移到组织细胞中的机制至关重要。这将使得能够为每种特定的预期用途适当选择电脉冲参数和质粒DNA构建体。从长远来看,这项审查应鼓励其他科学家考虑在基因治疗成熟时采用电辅助基因进行基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号